Cabio Bioengineering (Wuhan) Co., Ltd. Details
- Country/Region:China
- Province/State:Hubei
- City:Wuhan
- Operational Address:Rm. 504, Juxian Bldg., International Corporation Center, Special No. 1, Guanggu Ave., Wuhan, Hubei, China (Mainland)
- Business Type:Manufacturer
- Year Established:2004
- Year Start Exporting:2004
- Number Of Employees:301 - 500 People
- Total Revenue:US$50 Million - US$100 Million
- Average Lead Time:10 Day(s)
- Trade Capacity:Western Europe : 11.11% Eastern Asia : 11.11%
- Production Capacity:Factory Size : 1,000-3,000 square meters Annual Ou
- R&D Capacity:No. of R&D Staff :31 - 40 PeopleEquipment and Faci
- Main Products:Arachidonic Acid Powder, Arachidonic Acid Oil, Docosahexaenoic Acid,Algae DHA Powder, Algae DHA Oil, Docose Hexaenoie Acid ( DHA ), Infant Formula Ingredients, Health Food Ingredients,Animal Nutritions, Goat Milk Formula Ingredients,
- Address:504# juxian Building,International Corporation center, Special No.2 Road,Wuhan,China
- Main Markets:Western Europe, Eastern Asia, Mid East, Oceania, S
- Location:Hubei, China (Mainland)
- Website:Visit website
About Us
- CABIO Bioengineering (Wuhan) Co.,Ltd.(CABIO),is a hi-tech venture jointly founded by Wuhan Alking Bioengineering Co.,Ltd.and Cargill,Incorporated.It has two wholly-owned subsidiaries in Gedian and Jiangxia respectively.
CABIO is the first company in China to engage in the production of unsaturated fatty acid with fermentation technology;which mainly serves ARA and Docosahexaenoic acid derived from microalga(DHA algal oil) and other high-end food ingredients;
CABIO is the leading brand in the ARA industry in China;
CABIO is the only Chinese company whose ARA products have been approved as the NOVEL FOOD by European Commission and as GRAS by the U.S. FDA.
CABIO has taken the leading role in drafting state standards for food safety regarding ARA and DHA (with the fermentation method);
CABIO has two advanced plants manufacturing ARA and DHA monomers currently.
Category
Related Product